Though the side effects of these two classes are similar ... Here are a few important ones to keep in mind: In 2020, the H2 ...

Zantac 360 Famotidine may also be used for ... Ask a doctor before using this medicine if you are pregnant or breastfeeding. Some side effects may be more likely in older adults and in people ...

Since 2019, there have been 15 peer-reviewed epidemiological studies on the effects of ranitidine use on humans which reflect the scientific consensus that there is no consistent or reliable ...

Ask a doctor before using this medicine if you are pregnant or breastfeeding. Some side effects may be more likely in older adults and in people who have severe kidney disease. Common side effects ...

When to see a doctor If you have heartburn twice a week or more for a few weeks or if drugs like Mylanta, Pepcid, or Zantac don't provide ... and sleepiness as a side effect, temporarily helping ...

GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...

British pharmaceutical company GSK on Wednesday said it swung into a net loss in the third quarter after settling lawsuits in the United States surrounding its Zantac heartburn drug. GSK suffered ...

An over-the-counter medication sold today as Zantac 360 by Sanofi has a different active ingredient from the withdrawn versions of Zantac and has not raised questions about a cancer link.

Zantac hit the market in 1983 and we're just seeing court cases reach juries now. This, of course, means that any side effects -- temporary or permanent -- caused by Comirnaty, the brand name for ...

GSK Plc said it will pay as much as $2.2 billion to resolve about 80,000 US court cases related to allegations that its old reflux medication Zantac was contaminated with a suspected carcinogen.

GSK to pay $70 million to settle whistleblower lawsuit Pfizer and Sanofi also settling Zantac cases Boehringer Ingelheim faces trial, denies wrongdoing Oct 9 (Reuters) - GSK (GSK.L), opens new tab ...